Decreased blood–brain barrier expression of P-glycoprotein in Alzheimer’s disease: impact on pathogenesis and brain access of therapeutic agents
Formulation and packaging design for new chemical entities: examining specific populations and product repositioning
Den-Angio: a dendrimer-based probe for sensitive low-grade brain tumor imaging
Novel combined spray drying and microfluidic technique advances small-scale formulation
Tongue twister: bitter blocker-binding bud receptor bars bitter-molecule binding
Gene silencing is golden: downregulation of iron-storage protein gene sensitizes brain tumor cells to chemotherapy
Industry Update: The latest developments in therapeutic delivery
Society Spotlight: European Commission-supported development of targeted nanomedicines: did MediTrans make a difference?
Conference Report: Pharmaceutical development of biologics: fundamentals, challenges and recent advances
Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics
Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides
Poly(amidoamine) polymers: soluble linear amphiphilic drug-delivery systems for genes, proteins and oligonucleotides
See, reach, treat: ultrasound-triggered image-guided drug delivery
Phage therapy: delivering on the promise
Case studies with new excipients: development, implementation and regulatory approval